Report from the Advisory Committee on Immunization Practices (ACIP): Decision Not to Recommend Routine Vaccination of All Children Aged 2--10 Years with Quadrivalent Meningococcal Conjugate Vaccine (MCV4)

Pediatric Immunization: Meeting the Challenges of the 21st Century

PDF) Comparison of the safety and immunogenicity of an investigational and a licensed quadrivalent meningococcal conjugate vaccine in children 2-10 years of age

Meningococcal vaccine - Wikipedia

Immunization: Vaccine Updates Beyond COVID-19

Core Concepts - Immunizations in Adults - Basic HIV Primary Care - National HIV Curriculum

Pediatric and Adolescent Vaccines Update

Update on Routine Childhood and Adolescent Immunizations

Quadrivalent meningococcal tetanus toxoid-conjugate booster vaccination in adolescents and adults: phase III randomized study

2021 Update on Adult Vaccinations with a Focus on SARS-CoV-2/COVID-19

Meningococcal Vaccination Among Adolescents in the United States: A Tale of Two Age Platforms - ScienceDirect

ACIP Recommends New Penbraya Vaccine Be Added to Vaccine Schedule